2 Jun 2026
Structural Control of <scp>NLRP3</scp> Inflammasome Assembly and the Emerging Microprotein FrontierPublisher siteThe FASEB Journal, Inflammasome and immune disorders
UniversitiesHanan Eissa
Active, last published 2026
In autophagy in disease and therapy
Hanan
Eissa
Scholar“Research focused on Autophagy in Disease and Therapy and adjacent fields.”
University of Bisha
Claim Your Profile7
H-index
255
Citations
Hanan has not officially claimed their profile. If you are Hanan, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
anan Eissa is a researcher working on Autophagy in Disease and Therapy. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Hanan's work has been cited 255 times across 5 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Autophagy in Disease and Therapy×3Pancreatic function and diabetes×3Metabolism, Diabetes, and Cancer×3Inflammasome and immune disorders×2Pregnancy and preeclampsia studies×2
04 · Where I am
Affiliations
Affiliation on published researchUniversity of BishaDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
13 works12 Feb 2026
Adenosine A₂A receptor as a dual-acting molecular switch: Glial morphological changes and neurovascular tissue remodeling in neuroinflammation and neurodegenerationPublisher siteTissue and Cell, Adenosine and Purinergic Signaling
7 Feb 20261cites
FOXO3a-mediated structural and cellular remodeling in liver tissue: Implications for apoptosis and homeostasisPublisher siteTissue and Cell, FOXO transcription factor regulation
30 Sept 2025Open access3cites
Activation of nicotinamide phosphoribosyltransferase protects against unilateral renal ischemia-reperfusion injury via the NAD+/SIRT1/PGC-1α signaling pathway and modulation of NFκB/TNF-α/IL-6Publisher siteEuropean Journal of Pharmaceutical Sciences, Sirtuins and Resveratrol in Medicine
6 Sept 20253cites
Dual-sensitive gelatin-coated chitosan microparticles for targeted semaglutide pulmonary delivery: a novel approach to enhancing anti-inflammatory and anti-fibrotic effectsPublisher siteInternational Immunopharmacology, Inhalation and Respiratory Drug Delivery
4 Sept 20251cites
A Systems Biology Perspective on Childhood <scp>ADHD</scp> : Neurochemical Dysregulation, Brain‐Behavior Interactions, and Emerging TherapeuticsPublisher siteThe FASEB Journal, Attention Deficit Hyperactivity Disorder
18 Jun 2025Open access8cites
Innovative pH-responsive alginate-coated rosuvastatin-loaded chitosan nanoparticles: a targeted approach to inhibiting HMGB1-activated RAGE/TLR4-NFκB signaling in colonic inflammation in ratsPublisher siteFrontiers in Pharmacology, Advanced Glycation End Products research
6 Apr 20252cites
Vitamin D supplementation as a prophylactic therapy in the management of pre-eclampsia: Focus on VEGF, Ki67, oxidative stress markers in correlation to placental ultra structurePublisher siteLife Sciences, Pregnancy and preeclampsia studies
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Hanan?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you